Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Intimate Rose vs NextMeds

Intimate Rose
Graded #137

Higher grade

vs+3
NextMeds
Graded #207

Lower grade

The verdict

Intimate Rose takes it — 69.1/100 to 66.1/100.

Intimate Rose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIntimate Rose +10
65
55
Dose & formulationIntimate Rose +32
96
64
Clinical oversightNextMeds +1
76
77
Labs & monitoringNextMeds +9
52
61
FulfillmentNextMeds +20
64
84
Contract termsNextMeds +24
37
61
Intimate Rose · left barNextMeds · right bar

The numbers

MetricIntimate RoseNextMeds
WeighScore69.1/10066.1/100
GradeCC
Scorecard rank#137#207
Semaglutide$169/mo (all doses, compounded)$129/mo (plus a separate fee, compounded)
Tirzepatide$169/mo (all doses, compounded)$179/mo (plus a separate fee, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Intimate Rose

Graded #137 · C

Strengths

  • Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
  • Medication and free delivery included, HSA and FSA eligible, no contract
  • Backed by an established women's-health brand using the OpenLoop provider network

Where it loses points

  • State availability not published
  • Oral compounded GLP-1 only; no injectable option shown
  • No specific compounding pharmacy named (network fulfillment via OpenLoop)
NextMeds

Graded #207 · C

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard